Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

DESIGN OF OSMOTIC CONTROLLED DRUG DELIVERY SYSTEM. Edition No. 1

VDM Publishing House, Aug 2010, Pages: 232


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Osmotic systems, one of the oral dosage form utilize the principles of osmotic pressure for the delivery of drugs. Drug release from these systems is independent of pH and other physiological parameters and it is also possible to modulate the release characteristics by optimizing the properties of drug and system. The aim of present research was to design and optimize the three novel osmotic drug delivery systems viz. Swellable Porous Osmotic System (SPOP), Monolithic Osmotic Tablet System (MOTS) & Controlled Porosity Osmotic System (CPOP) for water soluble and low water soluble drugs and compare principle and methodology of CR design. Extended release formulations of Venlafaxine HCl and Glipizide were developed based on SPOP technology. Extended release formulations of Metoprolol Tartrate and Nifedipine were developed based on MOTS technology. Extended release formulations of Oxybutynin chloride and Atenolol were developed based on CPOP technology. Based on the present work it is clear that extended release formulations of drugs having different solubility profile can be developed using these technologies. The in-vivo pharmacokinetic study in beagle dog confirmed the same.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds